Participated · Seed · Jul 2026

Immigify offers a digital platform and management dashboard that combines a linked case-data model with built-in AI trained on patterns from successful cases to track visa and green-card eligibility, documents and deadlines. The product emphasizes step-by-step guidance, compliance monitoring and visible status dashboards to reduce missed deadlines and applicants stuck in status limbo. The company reports an early operational milestone of more than 400 visa approvals reached via the platform. Immigify positions itself for B2B adoption by advisors and employers and highlights integrations with adviser and corporate back offices as a next product priority. Planned product work includes standardizing case data, adding integrations, and maturing MLOps practices such as model updates, monitoring and versioning of guidance logic. Financially, the startup is supported by a $1.015 million Pre-Seed raise and accelerator placements in NMotion and Techstars to accelerate go-to-market and pilot opportunities.

Participated · Seed · Jun 2026

Driive builds Dot, an AI booking agent and scheduling engine designed specifically for home service trades such as HVAC, plumbing, electrical, and roofing. Dot automates appointment booking by factoring in drive time, lead qualification, route optimization, and post-sale scheduling to increase speed-to-lead and operational efficiency. The platform integrates with field teams, back-office tools, and customers to turn leads into booked appointments and scheduled jobs. Driive emphasizes bookings that account for where technicians already are and where they are going next, positioning itself as optimized for field-based businesses. The company is based in Lincoln, Nebraska, and plans to use its new pre-seed funding to scale Dot and expand its product and operations. The articles do not report revenue, user counts, or valuation.

Led · Seed · Apr 2026

Founded by Jack Sellwood and launched in 2025, Grapple offers an AI-powered, self-serve analytics platform that integrates data from databases, spreadsheets, Salesforce, QuickBooks and other apps to help nontechnical users generate reports without a data engineer. The product targets sales, marketing and finance teams to reduce the time, effort and cost of compiling analytics. Grapple has attracted early customers such as Guardify and Workshop and has received external validation through acceptance into the LAUNCH Accelerator and finalist placement in the 2025 Silicon Prairie Startup Week Pitch Competition. The company is based in Omaha and has engaged with local startup resources including 1 Million Cups Omaha and the Nebraska Startup Academy. Near-term plans include hiring, marketing, and executing a go-to-market strategy to quickly generate awareness and revenue.

Participated · Equity · Sep 2025

Nestimate offers a cutting-edge analytics, evaluation, and modeling platform that helps retirement plan advisors, consultants, sponsors, recordkeepers, and insurers bring lifetime-income products into 401(k) plans with confidence. By simplifying due diligence and education, the software removes the inertia that has historically slowed adoption of guaranteed income options. The company positions itself as a modern replacement for traditional pensions, aiming to secure retirees who will no longer have defined-benefit plans. Recognition from major financial institutions has made the platform an emerging industry staple. With fresh capital, Nestimate plans to accelerate product development, enhance customer support, and expand into new segments of the retirement market. Although specific revenue or user numbers were not disclosed, the firm emphasized growing demand from leading financial institutions already integrating its solution.

Led · Seed · Feb 2024

University Medical Devices (UMD) is a medical device developer commercializing MicroWash, a less-invasive nasal specimen collection system to improve sampling for upper respiratory infections. MicroWash was developed at the start of the COVID-19 pandemic to address the “tripledemic” of flu, COVID and RSV and to offer a more comfortable alternative to nasal swabs for labs, patients and providers. UMD commercializes technology from the University of Nebraska Medical Center and its commercialization arms UNeMed/UNeTech, and its leadership includes experts in pandemic medicine, telehealth and healthcare startup entrepreneurship. The company plans multiple sample collection products in the coming years and intends to launch an aggressive sales campaign in the first half of 2024 targeting distributors, national reference laboratories, health systems, health plans and government agencies. Device availability is anticipated later this year, and the company says proceeds will advance regulatory, manufacturing, packaging, sales and marketing infrastructure. UMD states the seed financing is a major step toward achieving profitability and sustainability.